ARCHIVES

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

NCI to Get 43 Out Of 200 New Aids Positions, 15 Others; Roper Says That’s “Fair”

November 11, 1988

DCE Advisors OK Concepts for Registry, Grants In Breast Cancer

June 25, 1993

Workshop Suggests Confirmation of Vitamin C Studies

December 7, 1990

Senate Confirms FDA Commissioner Von Eschenbach.

December 8, 2006

ASCO Letter To NCI Urges Increased Support for Clinical Trials, Training, Translational Research

March 6, 2009

DCT Board Okays Recompetition of $15 Million In contract Projects

November 10, 1978